BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 10544223)

  • 1. Genetic susceptibility to non-polyposis colorectal cancer.
    Lynch HT; de la Chapelle A
    J Med Genet; 1999 Nov; 36(11):801-18. PubMed ID: 10544223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
    Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
    Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of the hereditary colorectal carcinoma.
    Gatalica Z; Torlakovic E
    Fam Cancer; 2008; 7(1):15-26. PubMed ID: 17564815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary colorectal cancer].
    Park JG; Kim IJ
    Korean J Gastroenterol; 2005 Feb; 45(2):78-87. PubMed ID: 15725711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
    Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
    Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
    Soravia C; Bapat B; Cohen Z
    Schweiz Med Wochenschr; 1997 Apr; 127(16):682-90. PubMed ID: 9140167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences.
    Jass JR
    Fam Cancer; 2004; 3(2):93-100. PubMed ID: 15340259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited susceptibility to colorectal cancer.
    Rowley PT
    Annu Rev Med; 2005; 56():539-54. PubMed ID: 15660526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
    Couturier D
    Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple and complex genetics of colorectal cancer susceptibility.
    Baglioni S; Genuardi M
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):35-43. PubMed ID: 15264271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
    Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
    Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of hereditary non-polyposis syndrome (Lynch syndrome)].
    Kariv R; Goldberg Y; Soler I; Rosner G; Half E; Moshkowitz M; Vilkin A; Levi Z; Niv Y
    Harefuah; 2011 Apr; 150(4):392-6, 416. PubMed ID: 22164924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing.
    Riegert-Johnson DL; Johnson RA; Rabe KG; Wang L; Thomas B; Baudhuin LM; Thibodeau SN; Boardman LA
    Genet Test; 2007; 11(4):361-5. PubMed ID: 18294051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutation and genome instability.
    Olschwang S
    Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S33-7. PubMed ID: 10772416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical genetics of colorectal cancer.
    Lynch HT; Shaw TG
    Chin Clin Oncol; 2013 Jun; 2(2):12. PubMed ID: 25841492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colorectal carcinogenesis. 1. Hereditary predisposition and colorectal cancer].
    Karoui M; Tresallet C; Brouquet A; Radvanyi H; Penna C
    J Chir (Paris); 2007; 144(1):13-8. PubMed ID: 17369756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lynch or not Lynch? Is that always a question?
    Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
    Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.